UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

First presentation of malignancy to the emergency department: An analysis of patient demographics and cancer stage in an Irish tertiary referral center in a low income area

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e12616-e12616

2015

Volltextzugriff (PDF)

Activity and survival benefit of second-line chemotherapy (2L-Ctx) in advanced pancreatic adenocarcinoma (APC): Pooled analysis of the literature

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e15019-e15019

2013

Volltextzugriff (PDF)

Does RECIST-defined progression correlate with lack of further sunitinib (SU) benefit in advanced renal cell carcinoma (aRCC)?

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15093-e15093

2012

Volltextzugriff (PDF)

Response to second-line chemotherapy (Ctx) in advanced urothelial carcinoma: A pooled retrospective analysis of the correlation between objective response rate (ORR) and progression-free survival (PFS) and overall survival (OS)

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.354-354

2014

Volltextzugriff (PDF)

Genomic landscape of defective DNA damage response and repair mechanisms (DDR) across cancer types

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23219-e23219

2016

Volltextzugriff (PDF)

Benefit of chemotherapy (ctx) in elderly patients (pts) with advanced pancreatic adenocarcinoma (PC): A population-based analysis

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.310-310

2014

Volltextzugriff (PDF)

Renal cell carcinoma: A focus on elderly population in clinical trials

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20514-e20514

2015

Volltextzugriff (PDF)

A prognostic score for metastatic hormone sensitive prostate cancer in the era of high and low volume disease

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e16536-e16536

2016

Volltextzugriff (PDF)

Smoking status (SS) and influence on the clinical behavior of transitional cell carcinoma (TCC): An epidemiologic perspective

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15512-e15512

2014

Volltextzugriff (PDF)

FOLFIRINOX in pancreatic cancer: Can results be reproduced outside the clinical trial setting?

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15236-e15236

2014

Volltextzugriff (PDF)

Efficacy and tolerability of FOLFOX6 as first-line treatment for advanced gastric and esophagogastric junction cancers (AGC): A single-center experience

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e14705-e14705

2012

Volltextzugriff (PDF)

Correlation between platelet/lymphocyte ratio, neutrophil/lymphocyte ratio and response to neoadjuvant chemoradiation therapy in rectal cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15140-e15140

2016

Volltextzugriff (PDF)

Impact and correlation of mutational load (ML) and specific mutations (mts) assessed by limited targeted profiling (LTP) with PD-L1 tumour expression (exp) in resected non-small cell lung carcinoma (NSCLC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11587-11587

2017

Volltextzugriff (PDF)

Active surveillance of pulmonary metastases in renal cancer patients

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.445-445

2014

Volltextzugriff (PDF)

Does interval from histologic diagnosis (Dx) to start of chemotherapy (Ctx) impact survival in metastatic colorectal cancer (MCRC)?

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.615-615

2014

Volltextzugriff (PDF)

PD24-11 EVALUATION OF A MULTIMODAL STRATEGY TO ACCELERATE DRUG EVALUATIONS IN EARLY STAGE METASTATIC PROSTATE CANCER

The Journal of urology, 2017-04, Vol.197 (4), p.e456-e456

2017

Volltextzugriff (PDF)

Characterization of POLE-mutated (POLE+) urothelial carcinoma of the bladder and urinary tract (UC)

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.387-387

2017

Volltextzugriff (PDF)

NUT midline carcinoma in a young woman

Journal of clinical oncology, 2011-04, Vol.29 (12), p.e336-e339

2011

Volltextzugriff (PDF)

A correlative analysis of biochemical and radiologic hepatic disease in metastatic pancreatic adenocarcinoma (PA)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e15163-e15163

2013

Volltextzugriff (PDF)

An Irish breast cancer survivorship study: Are we meeting our patients' needs?

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20687-e20687

2013

Volltextzugriff (PDF)

Glycaemic status and survival in locally-advanced pancreatic adenocarcinoma

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2012-05, Vol.12 (3), p.e18-e18

2012

Volltextzugriff (PDF)

Influence of KRAS status, pattern of metastatic disease and age on survival in stage IV colorectal cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14683-e14683

2015

Volltextzugriff (PDF)

Carboplatin use in clinical stage one testicular seminoma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15549-e15549

2015

Volltextzugriff (PDF)

The era of geriatric oncology: Phase II/III trials over the decades

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20519-e20519

2015

Volltextzugriff (PDF)

DNA damage repair and response (DDR) gene alterations (alt) and response to PD1/PDL1 blockade in platinum-treated metastatic urothelial carcinoma (mUC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4509-4509

2017

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(49)
Berichte
(1)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

Humans
(7)
Life Sciences & Biomedicine
(6)
Male
(6)
Oncology
(6)
Science & Technology
(6)
Aged
(4)
Adult
(3)
Chemotherapy
(3)
Female
(3)
Urology
(3)
Antineoplastic Agents - Therapeutic Use
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Biology
(2)
Carcinoma, Renal Cell - Drug Therapy
(2)
Combined Modality Therapy
(2)
Disease Progression
(2)
Fatal Outcome
(2)
Kidney Neoplasms - Drug Therapy
(2)
Middle Aged
(2)
Pancreatic Neoplasms - Mortality
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First presentation of malignancy to the emergency department: An analysis of patient demographics and cancer stage in an Irish tertiary referral center in a low income area

Activity and survival benefit of second-line chemotherapy (2L-Ctx) in advanced pancreatic adenocarcinoma (APC): Pooled analysis of the literature

Does RECIST-defined progression correlate with lack of further sunitinib (SU) benefit in advanced renal cell carcinoma (aRCC)?

Response to second-line chemotherapy (Ctx) in advanced urothelial carcinoma: A pooled retrospective analysis of the correlation between objective response rate (ORR) and progression-free survival (PFS) and overall survival (OS)

Genomic landscape of defective DNA damage response and repair mechanisms (DDR) across cancer types

Benefit of chemotherapy (ctx) in elderly patients (pts) with advanced pancreatic adenocarcinoma (PC): A population-based analysis

Renal cell carcinoma: A focus on elderly population in clinical trials

A prognostic score for metastatic hormone sensitive prostate cancer in the era of high and low volume disease

Smoking status (SS) and influence on the clinical behavior of transitional cell carcinoma (TCC): An epidemiologic perspective

FOLFIRINOX in pancreatic cancer: Can results be reproduced outside the clinical trial setting?

Efficacy and tolerability of FOLFOX6 as first-line treatment for advanced gastric and esophagogastric junction cancers (AGC): A single-center experience

Correlation between platelet/lymphocyte ratio, neutrophil/lymphocyte ratio and response to neoadjuvant chemoradiation therapy in rectal cancer

Impact and correlation of mutational load (ML) and specific mutations (mts) assessed by limited targeted profiling (LTP) with PD-L1 tumour expression (exp) in resected non-small cell lung carcinoma (NSCLC)

Active surveillance of pulmonary metastases in renal cancer patients

Does interval from histologic diagnosis (Dx) to start of chemotherapy (Ctx) impact survival in metastatic colorectal cancer (MCRC)?

PD24-11 EVALUATION OF A MULTIMODAL STRATEGY TO ACCELERATE DRUG EVALUATIONS IN EARLY STAGE METASTATIC PROSTATE CANCER

Characterization of POLE-mutated (POLE+) urothelial carcinoma of the bladder and urinary tract (UC)

NUT midline carcinoma in a young woman

A correlative analysis of biochemical and radiologic hepatic disease in metastatic pancreatic adenocarcinoma (PA)

An Irish breast cancer survivorship study: Are we meeting our patients' needs?

Glycaemic status and survival in locally-advanced pancreatic adenocarcinoma

Influence of KRAS status, pattern of metastatic disease and age on survival in stage IV colorectal cancer

Carboplatin use in clinical stage one testicular seminoma

The era of geriatric oncology: Phase II/III trials over the decades

DNA damage repair and response (DDR) gene alterations (alt) and response to PD1/PDL1 blockade in platinum-treated metastatic urothelial carcinoma (mUC)

Suchergebnisse filtern